What is the appropriate management for a 12‑year‑old male with hemoglobin 13.7 g/dL, hematocrit 40.9 %, mean corpuscular volume 79 fL (microcytosis), serum iron 68 µg/dL, total iron‑binding capacity 405 µg/dL, transferrin saturation 17 %, and ferritin 21 ng/mL?

Management of Iron Deficiency in a 12-Year-Old Male

This 12-year-old male has clear iron deficiency (ferritin 21 ng/mL, transferrin saturation 17%, microcytosis) and should be started on oral ferrous sulfate 200 mg once daily on an empty stomach, but hemoglobinopathy screening with hemoglobin electrophoresis must be performed before initiating treatment to rule out thalassemia trait. 1, 2

Diagnostic Interpretation

The laboratory values confirm iron deficiency based on multiple parameters:

• Ferritin 21 ng/mL is well below the diagnostic threshold of 30-45 ng/mL for iron deficiency in the absence of inflammation 3, 4
• Transferrin saturation of 17% (calculated as serum iron 68 ÷ TIBC 405 × 100) is below the 20% threshold that has high sensitivity for diagnosing absolute iron deficiency 5, 6, 7
• MCV 79 fL with microcytosis indicates iron-deficient erythropoiesis 1, 8
• Hemoglobin 13.7 g/dL is at the lower end of normal for a 12-year-old male, representing iron deficiency without frank anemia 1, 2

Critical Differential Diagnosis Consideration

Before starting iron therapy, hemoglobin electrophoresis must be performed to exclude thalassemia trait, which is a common cause of microcytosis in children and can coexist with or mimic iron deficiency 9, 10:

• Thalassemia trait occurs in 10-21% of children with microcytosis in some populations 9, 10
• The MCV of 79 fL with relatively preserved hemoglobin (13.7 g/dL) raises concern for possible thalassemia trait, where MCV is disproportionately low relative to the degree of anemia 9
• Iron supplementation in thalassemia trait patients is unnecessary and potentially harmful 9
• If hemoglobin electrophoresis shows beta-thalassemia trait (elevated HbA2 >3.5%) or alpha-thalassemia trait is suspected, iron therapy should be withheld unless iron deficiency is confirmed by response to treatment 9, 10

First-Line Treatment Protocol

Oral ferrous sulfate 200 mg once daily is the recommended first-line therapy 11, 3, 4:

• Once-daily dosing is superior to multiple daily doses because oral iron increases serum hepcidin for up to 48 hours, blocking further absorption and increasing gastrointestinal side effects without additional benefit 11
• The dose should be taken on an empty stomach for optimal absorption 11
• Adding vitamin C 500 mg with the iron dose enhances absorption 11
• Alternative ferrous salts (ferrous fumarate, ferrous gluconate) are equally effective if ferrous sulfate is not tolerated 11

Monitoring Response to Treatment

Laboratory monitoring should follow a specific timeline 5, 11:

• Recheck complete blood count at 3-4 weeks to confirm response to oral iron 11, 4
• Hemoglobin should increase by 1-2 g/dL within 4-8 weeks of therapy 5
• If there is little or no hemoglobin response after 4 weeks, reconsider thalassemia trait or non-compliance 9, 4
• Ferritin levels should be rechecked after 3 months to confirm iron store repletion, with a goal ferritin of at least 50 ng/mL 5, 11
• Iron parameters should not be evaluated within 4 weeks of starting treatment as circulating iron interferes with assays 5

Investigation of Underlying Cause

The cause of iron deficiency must be identified in this adolescent male 3, 4:

• Dietary history is essential: inadequate dietary iron intake is the most common cause in children 1, 8, 2
• Screen for occult blood loss: gastrointestinal bleeding from conditions like inflammatory bowel disease, Helicobacter pylori gastritis, or parasitic infections 3, 4
• Consider malabsorption: celiac disease should be screened with tissue transglutaminase IgA antibody, as it commonly presents with iron deficiency in adolescents 11, 12, 4
• Assess for chronic inflammation: inflammatory bowel disease can cause both blood loss and functional iron deficiency 3

When to Consider Intravenous Iron

Intravenous iron is indicated if 5, 11, 3:

• Intolerance to at least two different oral iron preparations despite trying alternate-day dosing 11
• No hemoglobin rise after 4 weeks of adequate oral therapy 11
• Malabsorption conditions are identified (celiac disease, inflammatory bowel disease) 11, 3
• Ongoing blood loss that cannot be controlled 5

If intravenous iron is needed, ferric carboxymaltose 1000 mg infused over 15-20 minutes or ferric derisomaltose up to 20 mg/kg (not exceeding 1500 mg) are preferred formulations 5, 11

Common Pitfalls to Avoid

• Do not assume dietary deficiency is the sole cause without investigating for blood loss or malabsorption, especially if response to oral iron is suboptimal 3, 4
• Do not give iron supplements to patients with thalassemia trait unless confirmed iron deficiency coexists and responds to treatment 9
• Do not use multiple daily doses of oral iron, as this increases side effects without improving efficacy 11
• Do not check iron parameters within 4 weeks of starting treatment, as results will be spuriously elevated 5